BTMD insider trading
NasdaqGM Healthcarebiote Corp.: insider trade history from SEC Form 4 filings.
About biote Corp.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.
Company website: www.biote.com
BTMD insider activity at a glance
FilingIQ tracks 81 insider transactions for BTMD in filings since May 31, 2022. The most recent transaction is dated Aug 11, 2026.
Across the full history, 31 open-market purchases
and 6 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on BTMD insider trades is 58.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest BTMD Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BTMD?
- FilingIQ tracks 81 Form 4 insider transactions for BTMD (biote Corp.), covering filings from May 31, 2022 onwards. 2 of those are dated within the last 90 days.
- Are BTMD insiders net buyers or net sellers?
- Across the full Form 4 history for BTMD, 31 transactions (38%) were open-market purchases and 6 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BTMD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is BTMD in?
- biote Corp. (BTMD) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $70.13M.
Methodology & sources
Every BTMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.